Expression profile of shelterin components in plasma cell disorders. Clinical significance of POT1 overexpression

JULIETA PANERO; CARMEN STANGANELLI; JORGE ARBELBIDE; DOROTEA BEATRIZ FANTL; DANA KOHAN; GARCIA RIVELLO HERNAN; GABRIEL RABINOVICH; IRMA SLAVUTSKY

BLOOD CELLS MOLECULES AND DISEASES

ACADEMIC PRESS INC ELSEVIER SCIENCE

Lugar: Nueva York; Año: 2014 vol. 52 p. 134 - 139

1079-9796

The core complex of telomere-associated proteins, named the shelterin complex, plays a critical role in telomere protection and telomere length (TL) homeostasis. In this study, we have explored changes in the expression of telomere-associated genes POT1, TIN2, RAP1 and TPP1, in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM). A total of 154 patients: 70 with MGUS and 84 with MM were studied. Real-Time Quantitative RT-PCR was used to quantify gene expression. TL was evaluated by Terminal Restriction Fragments. Our data showed increased expression of POT1, TPP1, TIN2 and RAP1 in MM with respect to MGUS patients, with significant differences for POT1 gene (p=0.002). In MM, the correlation of gene expression profiles with clinical characteristics highlighted POT1 for its significant association with advanced clinical stages, high calcium and â2microglobulin levels (p=0.02) and bone lesions (p=0.009). In multivariate analysis, POT1 expression (p=0.04) was a significant independent prognostic factor for overall survival as well as the staging system (ISS) (p<0.02). Our findings suggest for the first time the participation of POT1 in the transformation process from MGUS to MM, and provide evidence of this gene as a useful prognostic factor in MM as well as a possible molecular target to design new therapeutic strategies.